Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nathan Everding

Hand Surgery Syracuse, NY Medical Doctor

NPI 1750556320 CMS profile 897233

5719 Widewaters Pkwy, Syracuse, NY 13214

Open in the dashboard

General payments

$97,537

105 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nathan Everding of Syracuse, NY is reported in the CMS Open Payments database as having received $97,537 across 105 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $34,141 18
2024 General $31,241 20
2023 General $19,456 25
2022 General $80 7
2021 General $2,950 4
2020 General $122 4
2019 General $9,547 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nathan Everding
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Nathan Everding were reported at $34,141. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Nathan Everding Hand Surgery median Middle half National median
2019 $9,547 $383 $106–$1,905 $163
2020 $122 $172 $51–$1,268 $114
2021 $2,950 $263 $71–$1,591 $132
2022 $80 $336 $87–$1,938 $149
2023 $19,456 $233 $81–$1,114 $160
2024 $31,241 $258 $88–$1,203 $164
2025 $34,141 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Shoulder Innovations, Inc. $66,325 35 payments
  2. Encore Medical, LP $28,614 36 payments
  3. Arthrex, Inc. $1,250 1 payment
  4. DePuy Synthes Sales Inc. $419 12 payments
  5. Stryker Corporation $369 7 payments
  6. Prodigy Surgical Distribution, Inc. $282 1 payment
  7. AxoGen $141 6 payments
  8. Skeletal Dynamics Inc $73 1 payment
  9. Boston Scientific Corporation $20 1 payment
  10. Smith+Nephew, Inc. $18 1 payment
  11. Other $26 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $72,070 17 payments
  2. Travel and Lodging $13,525 19 payments
  3. Honoraria $6,430 3 payments
  4. Food and Beverage $3,941 63 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,250 1 payment
  6. Education $282 1 payment
  7. Gift $39 1 payment
Products named General payments · program years 2019–2025
  1. InSet System $66,325 35 payments
  2. DJO SURGICAL Joint Implants $16,757 13 payments
  3. DJO SURGICAL Joint Implants $16,757 13 payments
  4. DJO SURGICAL Joint Implants $9,521 6 payments
  5. DJO Surgical AltiVate Reverse Joint Implants $5,169 14 payments
  6. DJO Surgical AltiVate Anatomic System Joint Implants $4,548 13 payments
  7. DJO Surgical AltiVate Anatomic System Joint Implants $2,802 2 payments
  8. DJO Surgical AltiVate Reverse Joint Implants $2,720 1 payment
  9. DJO Surgical Match Point System $1,105 12 payments
  10. MAKO $143 1 payment
  11. Other $1,384 45 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

778

Median for Orthopedic Surgery: 203

Drug cost

$7,409

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 228 $6,087
Meloxicam Generic 462 $1,206
Amoxicillin Generic 73 $62
Naproxen Generic 15 $54

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 88 billing codes

Paid by Medicare

$189,478

Of which drugs: $548

Medicare patients

579

Average age 75

Services billed

3,690

351 women, 228 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 71%
Diabetes 28%
Depression 26%
Chronic kidney disease 23%
Ischemic heart disease 22%
Atrial fibrillation 17%
COPD 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 35 2,120 $215
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 28 37 $195
Injection, methylprednisolone acetate, 40 mg J1030 Office 11 13 $60

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

105 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record